Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS139-TPS139 ◽  
Author(s):  
L. M. Krug ◽  
A. S. Tsao ◽  
S. Kass ◽  
V. W. Rusch ◽  
W. D. Travis ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Peptide Vaccine ◽  
Pleural Mesothelioma ◽  
Double Blinded

221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

Lung Cancer ◽  
2006 ◽  
Vol 54 ◽  
pp. S54 ◽  
Author(s):  
P.W. Szlosarek ◽  
D.A. Fennell ◽  
R.M. Rudd ◽  
M. Lind ◽  
M. Ranson ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document